期刊
TRENDS IN PHARMACOLOGICAL SCIENCES
卷 35, 期 10, 页码 537-547出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tips.2014.08.002
关键词
P2X7 receptor; ATP; neurodegenerative diseases; psychiatric disorders
资金
- Hungarian Research and Development Fund [NN107234]
- Hungarian Office of Science and Technology [TET_10-1-2011-0050]
- Hungarian Brain Research Program [KTIA_13_NAP-A-III/1]
- European Research Council [294313-SERRACO]
- Deutsche Forschungsgemeinschaft [IL 20/18-2, IL 20/21-1]
- Sino-German Centre for Research Promotion [GZ 919]
The ATP-sensitive homomeric P2X7 receptor (P2X7R) has received particular attention as a potential drug target because of its widespread involvement in inflammatory diseases as a key regulatory element of the inflammasome complex. However, it has only recently become evident that P2X7Rs also play a pivotal role in central nervous system (CNS) pathology. There is an explosion of data indicating that genetic deletion and pharmacological blockade of P2X7Rs alter responsiveness in animal models of neurological disorders, such as stroke, neurotrauma, epilepsy, neuropathic pain, multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), Alzheimer's disease, Parkinson's disease, and Huntington's disease. Moreover, recent studies suggest that P2X7Rs regulate the pathophysiology of psychiatric disorders, including mood disorders, implicating P2X7Rs as drug targets in a variety of CNS pathology.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据